Ricardo Gomez Huelgas

Titular Professor

University of Malaga

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Ricardo Gomez Huelgas is a Titular Professor at the University of Malaga, Spain. His research interests include cardiovascular safety and the efficacy of intensive blood pressure control, as well as the impact of newer glucose-lowering medications on chronic conditions such as type 2 diabetes and chronic obstructive pulmonary disease. He has also contributed to the fields of internal medicine and patient care guidelines, focusing on improving treatment outcomes for hospitalized patients with hyperglycemia.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (15)

Mónica Muñoz

Assistant Professor Doctor

Universidad Complutense de Madrid

SPAIN

Ricardo Gomez Huelgas

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Intermediate care units in internal medicine – From concept to consolidation

Cardiovascular safety and efficacy of intensive blood pressure control: how low should we go?

Effect of newer glucose-lowering medications on chronic obstructive pulmonary disease exacerbations among individuals with type 2 diabetes

Treatment of hospitalized patient with hyperglycemia: An EFIM critically appraised and adapted guideline

Comparative safety and efficacy analysis of GLP-1 receptor agonists and SGLT-2 inhibitors among frail individuals with type 2 diabetes in the era of continuous population ageing

Internal medicine in the 21st century: Back to the future

The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19

Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors combination therapy versus monotherapy and major adverse cardiovascular events: Do the benefits add up?

Tratamiento con urea oral en paciente con insuficiencia cardiaca e hiponatremia crónica

Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial

COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia

Kinematic Parameters That Can Discriminate in Levels of Functionality in the Six-Minute Walk Test in Patients with Heart Failure with a Preserved Ejection Fraction

Estimation of Functional Aerobic Capacity Using the Sit-to-Stand Test in Older Adults with Heart Failure with Preserved Ejection Fraction

Adipokines Profile and Inflammation Biomarkers in Prepubertal Population with Obesity and Healthy Metabolic State.

Perceptions about the Management of Patients with DM2 and COVID-19 in the Hospital Care Setting

C-Reactive Protein and Serum Albumin Ratio: A Feasible Prognostic Marker in Hospitalized Patients with COVID-19

Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research

Evolution of the Use of Corticosteroids for the Treatment of Hospitalised COVID-19 Patients in Spain between March and November 2020: SEMI-COVID National Registry

Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study

Collaborators (15)

Mónica Muñoz

Sebastian Mas-Fontao

María Rosa Bernal-López

Manuel Francisco Jiménez Navarro

Francisco J Tinahones

Luis Corral-Gudino

George Dalekos

Adrian Escriche-Escuder

Iván José Fuentes-Abolafio

Zdravko Kamenov

FRANCESC XAVIER COS CLARAMUNT

Antonio I Cuesta-Vargas

Jaana Lindström

Manuel Trinidad-Fernández

Carlos Pastor

Make your next move.